Related Experiment Videos

The effect of malate on propionate mitochondrial toxicity

T Matsuishi1, D A Stumpf, K Chrislip

  • 1Division of Neurology, Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois 60611.

Biochemical Medicine and Metabolic Biology
|October 1, 1991
PubMed

Insights

Propionic acidemia disrupts mitochondrial metabolism, causing toxic encephalopathy. L-malate may treat this by reducing toxic propionyl-CoA levels in liver mitochondria.

Area of Science:

  • Biochemistry
  • Mitochondrial Metabolism
  • Inborn Errors of Metabolism

Background:

  • Propionic acidemia is a metabolic disorder that can lead to toxic encephalopathy, mimicking Reye's syndrome.
  • This condition is characterized by the disruption of mitochondrial energy metabolism.
  • Elevated propionyl-CoA in the mitochondrial matrix is a key factor in the observed toxicity.

Purpose of the Study:

  • To investigate the protective effect of L-malate against propionate-induced mitochondrial dysfunction.
  • To elucidate the mechanism by which L-malate exerts its beneficial effects in propionic acidemia.
  • To explore the potential therapeutic role of L-malate in managing propionic acidemia.

Main Methods:

  • Isolated liver mitochondria were treated with propionate and L-malate.
  • Respiratory control ratios were measured to assess mitochondrial function.
  • Mitochondrial propionyl-CoA levels were quantified, and the effect of benzylmalonate (a dicarboxylate carrier inhibitor) was evaluated.

Main Results:

  • Propionate (5 mM) significantly inhibited liver mitochondria respiratory control ratios by 46%, correlating with increased matrix propionyl-CoA.
  • L-malate prevented the toxic effects of propionate and reduced matrix propionyl-CoA by 62%.
  • The protective effect of L-malate was abolished by benzylmalonate, suggesting involvement of the dicarboxylate carrier and succinate efflux.

Conclusions:

  • L-malate demonstrates a protective effect against propionate-induced mitochondrial toxicity in vitro.
  • The mechanism involves the stimulation of succinate efflux via the dicarboxylate carrier, reducing matrix propionyl-CoA.
  • L-malate shows promise as a potential therapeutic agent for patients with propionic acidemia.

Related Concept Videos